HKG:9820 Holdings Information

HKG:9820 is an equity ETF with a total of 46 individual holdings. The top holdings are Cash stock at 24.62%, WuXi Biologics at 11.10%, BeOne Medicines AG at 9.74%, Innovent Biologics at 9.07%, and WuXi AppTec at 8.76%.

Total Holdings

Top 10 Percentage

85.51%

Asset Class

Equity

ETF Category

Health Care

Assets

674.13M

PE Ratio

27.54

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	n/a	Cash	24.62%	n/a
2	HKG: 2269	WuXi Biologics (Cayman) Inc.	11.10%	1,485,535
3	ONC	BeOne Medicines AG	9.74%	24,080
4	HKG: 1801	Innovent Biologics, Inc.	9.07%	628,661
5	SHA: 603259	WuXi AppTec Co., Ltd.	8.76%	395,650
6	HKG: 9926	Akeso, Inc.	5.78%	413,023
7	HKG: 1177	Sino Biopharmaceutical Limited	4.46%	5,348,690
8	SHA: 600276	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	4.39%	874,968
9	HKG: 1548	Genscript Biotech Corporation	3.85%	660,366
10	HKG: 3692	Hansoh Pharmaceutical Group Company Limited	3.75%	748,489
11	HKG: 1530	3SBio Inc.	2.84%	1,171,306
12	HKG: 6990	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	2.35%	33,603
13	HKG: 2228	XtalPi Holdings Limited	1.82%	1,516,169
14	SHA: 688266	Suzhou Zelgen Biopharmaceuticals Co., Ltd.	1.70%	86,300
15	SHE: 300759	Pharmaron Beijing Co., Ltd.	1.43%	319,050
16	HKG: 0867	China Medical System Holdings Limited	1.05%	672,461
17	SHA: 603087	Gan & Lee Pharmaceuticals.	0.89%	150,800
18	SHA: 688578	Shanghai Allist Pharmaceuticals Co., Ltd.	0.84%	98,499
19	SHE: 300347	Hangzhou Tigermed Consulting Co., Ltd	0.69%	242,400
20	SHE: 002252	Shanghai RAAS Blood Products Co., Ltd.	0.62%	1,339,500
21	SHA: 688331	RemeGen Co., Ltd.	0.48%	23,023
22	SHA: 688180	Shanghai Junshi Biosciences Co., Ltd.	0.47%	175,320
23	SHA: 688506	Sichuan Biokin Pharmaceutical Co.,Ltd.	0.41%	9,300
24	SHA: 600161	Beijing Tiantan Biological Products Co., Ltd.	0.39%	188,680
25	SHA: 600566	Hubei Jumpcan Pharmaceutical Co., Ltd.	0.38%	92,200

Showing 25 of 46 holdings

Subscribe to see the full list

Activate Now

As of Sep 21, 2026